Filter posts

The Challenges and Risks of Adopting Foreign Price Controls

The Trump Administration is moving forward with a plan to import foreign price controls into …

Greenwood: A Critical Medicare Policy Has Been Delayed. Let’s Use This Opportunity to Get It Right...

In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies …

Greenwood Shines Spotlight on Insurance Industry Rip-off

Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a …

New Infographic Highlights the Remarkable Success of Medicare Part D

Since 2006, the Medicare prescription drug program – known as Medicare Part D – has …

A Flawed Bill That Would Harm Seniors

The Medicare prescription drug program has been a remarkable success for both seniors and taxpayers, …

Tackling the Thorny Problem of Alzheimer’s

Football fans are gearing up for tonight’s opening game when the defending Champion Seattle Seahawks …

Partnership for Part D Access Launches Today

BIO joins patient groups and other health care stakeholders today to announce the formation of …

IPAB: Bad Medicine for Patient Care

The Independent Payment Advisory Board is bad medicine for patient care, deficit reduction and containing …

Sen. Grassley Raises Concerns over 340B Program

In a memo written this week, Sen. Chuck Grassley (R-IA) responded to a recent Kaiser …

Medicare Part B: Barriers to Cancer Treatment

The National Patient Advocate Foundation (PAF) has seen a notable rise in calls for assistance …